Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Nov-Dec;34(7):810-3.
doi: 10.3747/pdi.2012.00347.

The use of exchange-free periods alternating with daily exchanges of icodextrin in the initial treatment of peritoneal dialysis-associated peritonitis: a safety study

Affiliations
Randomized Controlled Trial

The use of exchange-free periods alternating with daily exchanges of icodextrin in the initial treatment of peritoneal dialysis-associated peritonitis: a safety study

Maha Yehia et al. Perit Dial Int. 2014 Nov-Dec.
No abstract available

PubMed Disclaimer

Figures

Figure 1 —
Figure 1 —
Study design and procedures. (A) Study procedure for the Interventional group. (B) Procedure for the Control group. abs = antibiotics; D = dextrose.
Figure 2 —
Figure 2 —
Trends over the interventional phase of the study. (A) Mean serum sodium both groups over the intervention phase. (B) Mean serum CRP both groups over the intervention phase. (C) Mean log dialysate WCC both groups over the intervention phase. CRP = C-reactive protein; WCC = white cell count.

References

    1. Alobaidi HM, Coles GA, Davies M, LIoyd D. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. Nephrol Dial Transplant 1986; 1:16–21. - PubMed
    1. Keane WF, Comty CM, Verburgh HA, Peterson PK. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int 1984; 25:539–43. - PubMed
    1. Govindarajulu S, Hawley CM, Macdonald SP, Brown FG, Rosman JB, Wiggins KJ, et al. Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int 2010: 30(3); 311–9. - PubMed
    1. Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW, et al. Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int 2011;31;651–62. - PubMed
    1. Parikova A, Zweers MM, Strujik DG, Krediet RT. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions. Adv Perit Dial 2003; 19:186–90. - PubMed

MeSH terms

LinkOut - more resources